SCHEMBL12901771

SCHEMBL12901771

FC(F)(F)c1cnc(Nc2ccccn2)cc1Nc1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 6/20 0.51
MEN1 O00255 1/20 0.51
GFER P55789 1/20 0.51
KMT2A Q03164 1/20 0.51
ULK1 O75385 1/20 0.45
JAK2 O60674 4/20 0.44
JAK1 P23458 4/20 0.44
TYK2 P29597 4/20 0.44
JAK3 P52333 2/20 0.44
ABL1 P00519 1/20 0.44
MAPK9 P45984 5/20 0.43
LMNA P02545 1/20 0.43
KIT P10721 1/20 0.40
KCNH2 Q12809 1/20 0.40
TRPV1 Q8NER1 2/20 0.40
CTSC P53634 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
APEX1 P27695 1/20 0.39
TAS2R14 Q9NYV8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1230847 0.85 MEN1 (0.49) MAPK10MEN1GFERKMT2AULK1
SCHEMBL12901052 0.85 MEN1 (0.49) MAPK10MEN1GFERKMT2AULK1
SCHEMBL1231866 0.81 MAPK9 (0.70) MAPK10JAK2JAK1TYK2MAPK9
SCHEMBL1230908 0.78 PTK2 (0.58) MAPK10ULK1JAK2TYK2JAK3
SCHEMBL12886668 0.77 ULK1 (0.57) MAPK10MEN1KMT2AULK1JAK2
SCHEMBL12886656 0.76 MAPK10 (0.56) MAPK10MEN1GFERKMT2AULK1
SCHEMBL16876450 0.74 TAS2R14 (0.51) MAPK10MEN1GFERKMT2ACTSC
SCHEMBL26910995 0.72 KMT2A (0.64) MAPK10MEN1GFERKMT2AABL1
SCHEMBL29391624 0.72 KMT2A (0.76) MAPK10MEN1GFERKMT2ALMNA
SCHEMBL221242 0.72 KMT2A (0.76) MAPK10MEN1GFERKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580439-B2 Inhibitors of focal adhesion kinase THE SCRIPPS RESEARCH INSTITUTE (US) 2017-02-28 US disclosed
EP-2134689-B1 INHIBITORS OF FOCAL ADHESION KINASE SCRIPPS RESEARCH INST (US) 2014-04-23 EP disclosed
US-20130281443-A1 INHIBITORS OF FOCAL ADHESION KINASE THE SCRIPPS RESEARCH INSTITUTE (US) 2013-10-24 US disclosed
US-8501763-B2 Inhibitors of focal adhesion kinase THE SCRIPPS RESEARCH INSTITUTE (US) 2013-08-06 US disclosed
US-20110046121-A1 INHIBITORS OF FOCAL ADHESION KINASE THE SCRIPPS RESEARCH INSTITUTE (US) 2011-02-24 US disclosed
WO-2008115369-A2 INHIBITORS OF FOCAL ADHESION KINASE THE SCRIPPS RESEARCH INSTITUTE (US) 2008-09-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046121-A1 INHIBITORS OF FOCAL ADHESION KINASE PTK2, CABLES1, TNK2 MAPK10 590/4885MEN1 2909/4885GFER 3424/4885
US-20130281443-A1 INHIBITORS OF FOCAL ADHESION KINASE PTK2, CABLES1, TNK2 MAPK10 590/4885MEN1 2909/4885GFER 3424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.